About this webinar:
Chronic pain is one of the most pervasive and debilitating health challenges worldwide, disproportionately affecting women. Conditions such as fibromyalgia, endometriosis, and migraine not only cause ongoing physical suffering but also impact mental health, social functioning, and quality of life. Despite this, treatment options remain limited, and women’s experiences of chronic pain have historically been overlooked or minimized in medical research. In recent years, psychedelics have emerged as a potential tool in rethinking the treatment of chronic pain. With their ability to disrupt entrenched patterns of perception and modulate brain–body communication, these substances are being investigated for their capacity to reduce suffering, enhance resilience, and open new pathways for healing. Still, rigorous discussion is needed to understand how these treatments may intersect with women’s biology and health needs. Join us for an online webinar hosted by Hystelica, “Unraveling Chronic Pain: Psychedelics & Women’s Health,” where we will explore the latest science, share diverse perspectives, and create space for thoughtful community dialogue.
Learn how psychedelics can disrupt perception patterns and modulate brain–body communication to reduce suffering and enhance resilience in women with chronic pain.
Gain insights into how psychedelic research is shaping our understanding of pain pathways and the potential therapeutic applications for women.
Understand the importance of incorporating women’s biology and health needs into psychedelic science for more effective and inclusive treatments.
Dr. Grace Blest Hopley
Dr. Grace Blest-Hopley is a neuroscientist with a PhD from King’s College London and the founder of Hystelica. With over a decade of experience researching cannabinoids and psychedelics across clinical, recreational, and naturalistic settings, she is dedicated to advancing female-focused research and creating reliable, accessible education on women’s health and psychedelics.
Dr. Julia Bornemann
Dr. Julia Bornemann is a PhD candidate at the Centre for Psychedelic Research at Imperial College London. With a background in neuroscience, she has been involved in several psychedelic trials at Imperial.She now focuses her research on investigating the therapeutic potential of treating Chronic Pain conditions with psychedelic substances. Special interests include embodiment, mindfulness, compassion, movement, and public involvement in research.
Dr. Sinziana Pop
Dr. Sinziana Pop is a neuroscientist with over a decade of experience researching brain function and evolution. In recent years, her focus has shifted from curiosity-driven "blue sky" neuroscience to exploring unconventional approaches for treating chronic pain in women. Recognising that individual experiences are central to effective treatment, she is now pursuing psychedelic research, with the aim of designing clinical trials informed by women with lived experience of chronic pain.
Download now
Seal the deal with a bit more content that supports the main call to action.
£15.00